Cognitive outcome in urea cycle disorders

Molecular Genetics and Metabolism

Volumn 81, Issue SUPPL., 2004, Pages 58-62

  Gropman, Andrea L ^a   Batshaw, Mark L ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; ENZYME INHIBITOR; GLUTAMINE; METHIONINE SULFOXIMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; QUINOLINIC ACID;

BRAIN ATROPHY; BRAIN EDEMA; BRAIN FUNCTION; BRAIN HEMORRHAGE; CELL LOSS; COGNITIVE DEFECT; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; HUMAN; HYPERAMMONEMIA; MENTAL DEFICIENCY; MOTOR DYSFUNCTION; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; UREA CYCLE; UREA CYCLE DISORDER;

EID: 1642547106     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymgme.2003.11.016     Document Type: Article

References (46)

1. Brusilow S.W., Horwich A.L. Urea cycle enzymes. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic and Metabolic Bases of Inherited Disease. eighth ed. 2001;1909-1963 McGraw-Hill, New York.
2. Ricciuti F., Gelehrter T.D., Rosenberg L.E. X-chromosome inactivation in human liver: confirmation of X-linkage of ornithine transcarbamylase. Am. J. Hum. Genet. 28:1976;332-338.
3. Lindgren V., Martinville B., Horwich A.L., Rosenberg L.E., Francke U. Human ornithine transcarbamylase locus mapped to band Xp21.1 near the Duchenne muscular dystrophy locus. Science. 226:1984;698-700.
4. Brusilow S.W., Maestri N.E. Urea cycle disorders: diagnosis, pathophysiology and therapy. Adv. Pediatr. 43:1996;127-170.
5. Maestri N.E., Clissold D.M.A., Brusilow S. Neonatal onset ornithine transcarbamylase deficiency. J. Pediatr. 134:1999;268-272.
6. Msall M., Batshaw M.L., Suss R., Brusilow S.W., Mellits E.D. Neurologic outcome in children with inborn errors of urea synthesis. N. Engl. J. Med. 310:1984;1500-1505.
7. Uchino T., Endo F., Matsuda I. Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan. J. Inherit. Metab. Dis. 21:1998;151-159.
8. Bachmann C. Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation. Eur. J. Pediatr. 162:2003;410-416.
9. Batshaw M.L., Msall M., Trojak J. The risk of serious illness in carriers of ornithine transcarbamylase deficiency. J. Pediatr. 108:1986;236-241.
10. Msall M., Monahan P.S., Chapanis N., Batshaw M.L. Cognitive development in Children with inborn errors of urea synthesis. Acta Paediatr. Jpn. 30:1988;435-441.
11. Ausems M.G., Bakker E., Berger R., Duran M., van Diggelen O.P., Keulemans J.L., de Valk H.W., Kneppers A.L., Dorland L., Eskes P.F., Beemer F.A., Poll-The B.T., Smeitink J.A. Asymptomatic and late-onset ornithine transcarbamylase deficiency caused by a A208T mutation: clinical, biochemical and DNA analyses in a four-generation family. Am. J. Med. Genet. 68:1997;236-239.
12. Batshaw M.L., Roan Y., Jung A.L., Rosenberg L.A., Brusilow S.W. Cerebral dysfunction in asymptomatic carriers of ornithine transcarbamylase deficiency. N. Engl. J. Med. 302:1980;482-485.
13. Gyato K., Wray J., Huang C.J., Yudkoff M., Batshaw M.L. Metabolic and neuropsychological phenotype in women heterozygous for ornithine transcarbamylase deficiency. Ann. Neurol. 55:2004;80-86.
14. Butterworth R.F. Effects of hyperammonaemia on brain function. J. Inherit. Metab. Dis. 21(Suppl. 1):1998;6-20.
15. Braissant O., Henry H., Villard A.-M., Zurich M.-G., Loup M., Eilers B., Parlascino G., Matter E., Boulat O., Honegger P., Bachmann C. Ammonium-induced impairment of axonal growth is prevented through glial creatinine. J. Neurosci. 22:2002;9810-9820.
16. Bachmann C. Mechanisms of hyperammonemia. Clin. Chem. Lab. Med. 40:2002;653-662.
17. Willard-Mack C.L., Koehler R.C., Hirata T., Cork L.C., Takahashi H., Traystman R.J., Brusilow S.W. Inhibition of glutamine synthetase reduces ammonia-induced astrocyte swelling in rat. Neuroscience. 71:1996;589-599.
18. Connelly A., Cross J.H., Gadian D.G., Hunter J.V., Kirkham F.J., Leonard J.V. Magnetic resonance spectroscopy shows increased brain glutamine in ornithine carbamoyl transferase deficiency. Pediatr. Res. 33:1993;77-81.
19. Choi C.G., Yoo H.W. Localized proton MR spectroscopy in infants with urea cycle defect. Am. J. Neuroradiol. 22:2001;834-837.
20. Bachmann C., Colombo J.P. Increase of tryptophan and 5-hydroxyindole acetic acid in the brain of ornithine carbamoyltransferase deficient sparse-fur mice. Pediatr. Res. 18:1984;372-375.
21. Batshaw M.L., Robinson M.B., Hyland K., Djali S., Heyes M.P. Quinolinic acid in children with congenital hyperammonemia. Ann. Neurol. 34:1993;676-681.
22. Robinson M.B., Hopkins K., Batshaw M.L., McLaughlin B.A., Heyes M.P., Oster-Granite M.L. Evidence of excitotoxicity in the brain of the ornithine carbamoyltransferase deficient sparse fur mouse. Brain Res. Dev. Brain Res. 90:1995;35-44.
23. Hyman S.L., Parke J.C., Porter C., Thomas G.H., Jankel W., Batshaw M.L. Anorexia and altered serotonin metabolism in a patient with argininosuccinic aciduria. J. Pediatr. 108:1986;705-709.
24. Hyman S.L., Porter C.A., Page T.J., Iwata B.A., Kissel R., Batshaw M.L. Behavior management of feeding disturbances in urea cycle and organic acid disorders. J. Pediatr. 111:1987;558-562.
25. Ratnakumari L., Qureshi I.A., Butterworth R.F. Loss of [3H]MK801 binding sites in brain in congenital ornithine transcarbamylase deficiency. Metab. Brain Dis. 10:1995;249-255.
26. Butterworth R.F. Evidence for forebrain cholinergic neuronal loss in congenital ornithine transcarbamylase deficiency. Metab. Brain Dis. 15:2000;83-91.
27. Batshaw M.L. Hyperammonemia. Curr. Probl. Pediatr. 14:1984;1-69.
28. Drogari E., Leonard J.V. Late onset ornithine carbomyl transferase deficiency in males. Arch. Dis. Child. 63:1988;1363-1367.
29. Capistrano-Estrada S., Marsden D.L., Nyhan W.L., Newbury R.O., Krous H.F., Tuchman M. Histopathological findings in a male with late-onset ornithine transcarbamylase deficiency. Pediatr. Pathol. 14:1994;235-243.
30. Michalak A., Butterworth R.F. Ornithine transcarbamylase deficiency: pathogenesis of the cerebral disorder and new prospects for therapy. Metab. Brain Dis. 12:1997;171-182.
31. Filloux F., Townsend J.J., Leonard C. Ornithine transcarbamylase deficiency: neuropathologic changes in acquired in utero. J. Pediatr. 108:1986;942-945.
32. Maestri N.E., Hauser E.R., Bartholomew D., Brusilow S.W. Prospective treatment of urea cycle disorders. J. Pediatr. 119:1991;923-928.
33. Kendall B.E., Kingsley D.P., Leonard J.V., Lingam S., Oberholzer V.G. Neurological features and computed tomography of the brain in children with ornithine carbamoyl transferase deficiency. J. Neurol. Neurosurg. Psychiatry. 46:1983;28-34.
34. Takayanagi M., Ohtake A., Ogura N., Nakajima H., Hoshino M. A female case of ornithine transcarbamylase deficiency with marked computed tomographic abnormalities of the brain. Brain Dev. 6:1984;58-60.
35. Christodoulou J., Qureshi A., McInnes R.R., Clarke J.T.R. Ornithine transcarbamylase deficiency presenting with strokelike episodes. J. Pediatr. 122:1993;423-425.
36. Kurihara A., Takanashi J.-I., Tomita M., Kobayashi K., Ogawa A., Kanazawa M., Yamamoto S., Kohno Y. Magnetic resonance imaging in late-onset ornithine transcarbamylase deficiency. Brain Dev. 25:2003;40-44.
37. Takanashi J., Kurihara A., Tomita M., Kanazawa M., Yamamoto S., Morita F., Ikehira H., Tanada S., Kohno Y. Distinctly abnormal brain metabolism in late-onset ornithine transcarbamylase deficiency. Neurology. 59:2002;210-214.
38. Batshaw M.L., Brusilow S., Waber L., Blom W., Brubakk A.M., Burton B.K., Cann H.M., Kerr D., Mamunes P., Matalon R., Myerberg D., Schafer I.A. Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion. N. Engl. J. Med. 306:1982;1387-1392.
39. Plum F., Posner J.B. The Diagnosis of Stupor and Coma Edition 3. 1982;FA Davis Company, Philadelphia.
40. Rowe P.C., Newman S.L., Brusilow S.W. Natural history of symptomatic partial ornithine transcarbamylase deficiency. N. Engl. J. Med. 314:1986;541-547.
41. Ahrens M.J., Berry S.A., Whitley C.B., Markowitz D.J., Plante R.J., Tuchman M. Clinical and biochemical heterogeneity in females of a large pedigree with ornithine transcarbamylase deficiency due to the R141Q mutation. Am. J. Med. Genet. 66:1996;311-315.
42. Arn P.H., Hauser E.R., Thomas G.H., Herman G., Hess D., Brusilow S.W. Hyperammonemia in women with a mutation at the ornithine carbamoyltransferase locus. N. Engl. J. Med. 322:1990;1652-1655.
43. Maestri N.E., Brusilow S.W., Clissold D.B., Bassett S.S. Long-term treatment of girls with ornithine transcarbamylase deficiency. N. Engl. J. Med. 335:1996;855-859.
44. Maestri N.E., Lord C., Glynn M., Bale A., Brusilow S.W. The phenotype of ostensibly healthy women who are carriers for ornithine transcarbamylase deficiency. Medicine. 77:1998;389-397.
45. Yudkoff M., Daikhin Y., Nissim I., Jawad A., Wilson J., Batshaw M. In vivo nitrogen metabolism in ornithine transcarbamylase deficiency. J. Clin. Invest. 98:1996;2167-2173.
46. Yudkoff M., Daikhin Y., Ye X., Wilson J.M., Batshaw M.L. In vivo measurement of ureagenesis with stable isotopes. J. Inherit. Metab. Dis. 21:1998;21-29.